Crsp) crispr therapeutics ag's current earnings per share (eps) is $5.31. Wall street stock market & finance report, prediction for the future:
Crispr therapeutics ag stock forecast.
Crispr stock 5 year forecast. In the medium term (3months), crsp's stock price. Today, crispr is already remarkable for. Worst decision, besides all the other great stocks i sold in march.
, crispr therapeutics ag stock forecast, crsp forecast tomorrow, crispr therapeutics ag technical analysis, crsp stock future price, crispr therapeutics ag. Crispr therapeutics stock price target raised to $155 from $105 at oppenheimer. Over the next 52 weeks, crispr therapeutics ag has on average historically risen by 40.1 % based on the past 5 years of stock performance.
7, 2020 at 7:27 a.m. The global crispr gene editing market was valued at $846.2 million in 2019 and is expected to reach $10,825.1 million by 2030, registering a cagr of 26.86% during the forecast. Get our premium forecast now, from only $8.49!
I started buying in at $18 a share in 2017. For crispr therapeutics ag stock forecast 2022, 12 predictions are offered for each month of 2022 with average crispr therapeutics ag stock forecast of $74.43, a high forecast of $83.41, and a low forecast of $69.63. On average, analysts forecast that crsp's eps will be $4.81 for 2021, with the lowest eps forecast at $4.37, and the highest eps forecast at $5.33.
Find the latest crispr therapeutics ag (crsp) stock quote, history, news and other vital information to help you with your stock trading and investing. Crsp stock forecast our latest prediction for crispr therapeutics ag's stock price was made on the dec. 5 year crispr therapeutics ag forecast:
Positive dynamics for crispr therapeutics shares will prevail with possible volatility of 5.020%. Crispr therapeutics ag has risen higher in 3 of those 5 years over the subsequent 52 week period, corresponding to a historical accuracy of 60 % 973.313 * about the crispr therapeutics ag stock forecast as of 2021 december 05, sunday current price of crsp stock is 70.030$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).
According to the issued ratings of 16 analysts in the last year, the consensus rating for crispr therapeutics stock is buy based on the current 4 hold ratings and 12 buy ratings for crsp. Kept accumulating for 2+ years then like a complete goddamn moron sold it all off during the march crash last year. Your current $100 investment may be up to $356.49 in 2026.
4, 2017 when the stock price was at 18.26$.
